- Home
- MTSI vs INM Comparison
MTSI vs INM Comparison
Compare MTSI & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTSI | INM |
|---|---|---|
| Founded | 1950 | 1981 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.0B | 7.1M |
| IPO Year | 2011 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MTSI | INM |
|---|---|---|
| Price | $249.20 | $1.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $257.60 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 66.9K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 62.68 |
| EPS | ★ 2.52 | N/A |
| Revenue | ★ $967,258,000.00 | $4,942,633.00 |
| Revenue This Year | $23.55 | N/A |
| Revenue Next Year | $17.74 | N/A |
| P/E Ratio | $95.25 | ★ N/A |
| Revenue Growth | ★ 32.58 | 7.50 |
| 52 Week Low | $122.30 | $0.58 |
| 52 Week High | $418.90 | $2.50 |
Technical Indicators
Market Signals| Indicator | MTSI | INM |
|---|---|---|
| Relative Strength Index (RSI) | 37.37 | 35.71 |
| Support Level | $203.76 | $1.03 |
| Resistance Level | $252.55 | $1.40 |
| Average True Range (ATR) | 11.40 | 0.06 |
| MACD | -1.62 | -0.01 |
| Stochastic Oscillator | 8.41 | 13.04 |
Price Performance
Historical ComparisonAbout MTSI MACOM Technology Solutions Holdings Inc.
MACOM Technology Solutions Holdings Inc is a provider of analog, digital, and mixed-signal semiconductor solutions to original equipment manufacturers and distributors. These solutions are found in systems for industrial, medical, scientific, and test and measurement markets. The firm's portfolio of products includes integrated circuits, multichip modules, power pallets and transistors, diodes, amplifiers, switches and switch limiters, passive and active components, and complete subsystems.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.